Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis

Journal of Pathology

Volumn 191, Issue 4, 2000, Pages 426-433

  Ikeda, Mika ^a,b   Hosoda, Yasuhiro ^a   Hirose, Shigemichi ^a   Okada, Yasunori ^a   Ikeda, Eiji ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Isoform; KDR; Neuropilin 1; Rheumatoid arthritis; VEGF

Indexed keywords

COMPLEMENTARY DNA; NEUROPILIN; RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0033841718     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH649>3.0.CO;2-E     Document Type: Article

References (34)

1. Angiogenesis. Implication for rheumatoid arthritis
2. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: Reduction of vascular endothelial growth factor (VEGF)
3. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
4. Vascular endothelial growth factor is a secreted angiogenic mitogen
5. Vascular permeability factor, an endothelial cell mitogen related to PDGF
6. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
7. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
8. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
9. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
10. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing
11. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
12. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
13. Nucleotide sequence and expression of novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
14. Identification of a new endothelial cell growth factor tyrosine kinase
15. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
16. Neuropilin is a receptor for the axonal chemorepellent semaphorin III
17. Neuropilin-I is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
18. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
19. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165
20. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
21. Vascular endothelial growth factor, a cytokine modulating endothelial function in rheumatoid arthritis
22. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
23. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
24. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
25. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
26. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium
27. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor
28. Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas
29. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
30. Vascular endothelial growth factor
31. Vascular endothelial growth factor induces endothelial fenestrations in vitro
32. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
33. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
34. Proteinases and matrix degradation